Method Validation

UPLC-MS/MS method validation was performed according to US Food and Drug
Administration (FDA) and European Medicines Agency (EMA) guidelines. Seven calibrators ranging from 10.00-1000 ng/mL (tryptanthrin) and 30.0-3000 ng/mL (indolinone) were injected at increasing concentrations, after a blank sample (blank HBSS) and a zero sample (HBSS only spiked with I.S.). Calibration curves were validated through six QCs (QCL, QCM, and QCH) that were inserted randomly into each analytical run. Calibrators and QCs were analyzed in duplicate. Carryover was assessed by directly injecting an extracted blank after both replicates of the upper limit of quantification (ULOQ). Specificity and selectivity were evaluated by six blank samples and six QC samples at the LLOQ (duplicates, three different batches of HBSS), respectively. Intra-run repeatability of the methods was evaluated by injecting six replicates at five concentration levels (LLOQ, QCL, QCM, QCH, and ULOQ). To assess dilution integrity, a solution of analyte (4000 ng/mL tryptanthrin or 15000 ng/mL indolinone) in HBSS was prepared and then further diluted ten-and hundredfold.
Absolute recovery was determined at three concentration levels (QCL, QCM, and QCH) by comparing the peak areas of six extracted QC samples with six unextracted samples (= 100% recovery). Short-term stabilities were assessed with six replicates at two concentration levels (QCL and QCH), after 3 h at RT, and after three freeze/thaw cycles. Long-term stability was determined by three replicates at the same concentration levels (QCL, QCM, and QCH). After storage for a minimum of 6 days (below -65°C), samples were analyzed by a freshly prepared calibration curve. 
